{
    "nct_id": "NCT04401267",
    "official_title": "Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma",
    "inclusion_criteria": "* Patient is being treated for newly diagnosed acute lymphoblastic leukemia or lymphoma (ALL) on the TOT17 protocol. Patients do not need to be hypertensive to enroll.\n* Patient is 10 years of age or older at the time of enrollment on TOT17.\n* Patient has completed â‰¤ 4 days of protocol therapy (patients are eligible on Day 4 of TOT17 therapy).\nHealthy volunteers allowed\nMust have minimum age of 10 Years",
    "exclusion_criteria": "* Moderate-severe renal dysfunction (glomerular filtration rate <45 ml/min/1.73m2).\n* Down's syndrome (germline Trisomy 21) or other syndrome resulting in growth delay or alterations in stature.\n* Chronic inability to ambulate. Patients with limitations in movement due to acute complications of leukemia/lymphoma are not excluded.\n* Permanent contraindication to MRI evaluation.\n* Participants who are pregnant or lactating. Males or females of reproductive potential must agree to use effective contraception for the duration of study participation.\n* Inability or unwillingness of research participant or legal guardian/representative to give written informed consent.",
    "miscellaneous_criteria": ""
}